Tributylphosphine → 5(s)-(1,2,4-Oxadiazol-3-yl-aminomethyl)-3-(3,5-difluoro-4-(1-(2(s),3-dihydroxypropanoyl)-1,2,5,6-tetrahydropyrid-4-yl)phenyl)oxazolidin-2-one

HRID 1582369노트

반응식

HRID 1582369 반응식
[OH:1][C@@H:2]([CH2:33][OH:34])[C:3]([N:5]1[CH2:10][CH2:9][C:8]([C:11]2[C:16]([F:17])=[CH:15][C:14]([N:18]3[CH2:22][C@H:21]([CH2:23][NH:24]C4ON=C(C)C=4)[O:20][C:19]3=[O:31])=[CH:13][C:12]=2[F:32])=[CH:7][CH2:6]1)=[O:4].C(OC(N[C:43]1[N:47]=[CH:46][O:45][N:44]=1)=O)(C)(C)C.C(P(CCCC)CCCC)CCC.N(C(N1CCCCC1)=O)=NC(N1CCCCC1)=O>C1COCC1>[O:45]1[CH:46]=[N:47][C:43]([CH:23]([NH2:24])[C@H:21]2[O:20][C:19](=[O:31])[N:18]([C:14]3[CH:13]=[C:12]([F:32])[C:11]([C:8]4[CH2:9][CH2:10][N:5]([C:3](=[O:4])[C@@H:2]([OH:1])[CH2:33][OH:34])[CH2:6][CH:7]=4)=[C:16]([F:17])[CH:15]=3)[CH2:22]2)=[N:44]1

참가 물질

6

반응물 4

HCID 13831TributylphosphineHCID 730421,1'-(Azodicarbonyl)dipiperidineHCID 22014528tert-butyl N-(1,2,4-oxadiazol-3-yl)carbamateHCID 695848453-(4-(1-(2(S),3-Dihydroxypropanoyl)-1,2,5,6tetrahydropyrid-4-yl)-3,5-difluorophenyl)-5(S)-(3-methylisoxazol-5-ylaminomethyl)oxazolidin-2-one

생성물 1

HCID 698904365(s)-(1,2,4-Oxadiazol-3-yl-aminomethyl)-3-(3,5-difluoro-4-(1-(2(s),3-dihydroxypropanoyl)-1,2,5,6-tetrahydropyrid-4-yl)phenyl)oxazolidin-2-one수율 45.6%

시약·촉매·용매 1

HCID 8028Tetrahydrofuran용매

반응 조건

온도
0 °C

실험 절차

To a stirred solution of the appropriate intermediate of Example 20 (600 mg, 1.37 mmol) in anhydrous THF (30 ml) under an atmosphere of nitrogen was added 3-t-butyloxycarbonylamino-1,2,4-oxadiazole (304 mg, 1.64 mmol) and tri-n-butylphosphine (510 μL, 2.05 mmol). The mixture was cooled to 0° C. and 1,1′-(azodicarbonyl)-di-piperidine (518 mg, 2.05 mmol) was added portionwise. The reaction was allowed to warm to room temperature and stir for 18 hours. The THF was removed under reduced pressure and the resulting residue taken into dichloromethane (15 ml) and cooled to 0° C. A white solid precipitated and the solution was filtered and purified by MPLC (Merck 9385 silica, 40-60% ethyl acetate in iso-hexane). The solvent was removed under reduced pressure to give a clear, colourless oil which was triturated with ether to yield the title compound as a fine white powder (291 mg, 35%). 1H-NMR (300 MHz, DMSO-d6): δ=1.31 (d, 6H), 1.47 (s, 9H), 2.27-2.48 (m, 2H), 3.61-4.28 (m, 10H), 4.87-5.02 (m, 2H), 5.89 (broad s, 1H), 7.33 (d, 2H), 9.54 (s, 1H). MS: ESP+ (M+H)+606.

후처리

  1. temperatureto warm to room temperature
  2. customThe THF was removed under reduced pressure
  3. temperaturecooled to 0° C
  4. customA white solid precipitated
  5. filtrationthe solution was filtered
  6. custompurified by MPLC (Merck 9385 silica, 40-60% ethyl acetate in iso-hexane)
  7. customThe solvent was removed under reduced pressure
  8. customto give a clear, colourless oil which
  9. customwas triturated with ether

출처 및 근거

ORD 기록
ord-94a6e04910794a2d84f661ad66f96785
출처 데이터셋
uspto-grants-2004_05
특허 번호
US06734200B1

반응 노트

불러오는 중…